| To Measure Post Operative Pain Severity by Using Two Different Intra Canal Medicaments Calcium Hydroxide and Triple Antibiotic Paste in Teeth with Single Roots and Periapical Disease Called Apical Periodontitis (NCT06821763) | Komal Ashraf Khan | 2025-05-01 |
| Comparison of Elranatamab and Lenalidomide Versus Daratumumab and Lenalidomide as Post-transplant Maintenance Therapy in Patients With Newly Diagnosed Myeloma (ElMMA) (NCT06931704) | Nantes University Hospital | 2025-05-01 |
| Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease (NCT06627751) | Roswell Park Cancer Institute | 2025-05-01 |
| NanO2 in Large VessEL Occlusion Stroke (NOVEL) (NCT06821347) | NHS Greater Glasgow and Clyde | 2025-05-01 |
| Obinutuzumab With CHOP Versus Obinutuzumab With Bendamustine in the Treatment of Newly Diagnosed Follicular Lymphoma Grade 3A (NCT06961500) | Sun Yat-sen University | 2025-05-01 |
| The Study of Different Cycles of High-dose Dexamethasone in the Treatment of ITP (NCT06913374) | Shandong University | 2025-05-01 |
| A Randomized Controlled Study of Endoscopic Cryoablation Combined With PD-1 Inhibitor for Maintenance Therapy in Advanced Gastric Cancer (NCT06957977) | Zhongguang Luo, MD | 2025-05-01 |
| Magnesium Sulfate in Addition to Bupivacaine in Ultrasound-guided Transmuscular Quadratus Lumborum Block for Post-Operative Analgesia After Total Hip Arthroplasty (NCT06956950) | Tanta University | 2025-05-01 |
| Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals with Fragile-X Syndrome (NCT06261502) | Université de Sherbrooke | 2025-05-01 |
| The PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cytoreductive Surgery and HIPEC in Ovarian Cancer (NCT07460180) | The Netherlands Cancer Institute | 2025-05-01 |
| Ultrasound Guided Emergency Physician Performed Erector Spinae Nerve Block for Rib Fracture Analgesia (NCT04168710) | Yale University | 2025-05-01 |
| Genetically Modified T Cells Against Ovarian Cancer (NCT03184753) | Shenzhen Geno-Immune Medical Institute | 2025-05-01 |
| Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma (NCT06933394) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2025-05-01 |
| CD73/AXL Targeted HypoSti.CAR-T Cells in CD73/AXL Positive Advanced/Metastatic Solid Tumors (NCT06939270) | Chinese PLA General Hospital | 2025-05-01 |
| Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia (NCT06869265) | Peking University People's Hospital | 2025-05-01 |
| Lemborexant to Prevent Post-operative Delirium in Cardiac Surgery Patients (NCT06648681) | University of British Columbia | 2025-05-01 |
| Illuminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation (NCT06956326) | Lars Hvid | 2025-05-01 |
| CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy (NCT06336434) | National Institute of Allergy and Infectious Diseases (NIAID) | 2025-05-01 |
| Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid Tumors (NCT06955390) | Henan Cancer Hospital | 2025-05-01 |
| Calcium Administration in Life-saving Management During Massive Hemorrhage (NCT06820645) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2025-05-01 |
| A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer (NCT06890832) | Jina Pharmaceuticals Inc. | 2025-05-01 |
| Efficacy of Topical Cannabidiol for Eczema (NCT06994520) | Khon Kaen University | 2025-05-01 |
| Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study (NCT06929169) | Maximo Agustin Schiavone | 2025-05-01 |
| A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia (NCT06803823) | Ono Pharmaceutical Co., Ltd. | 2025-05-01 |
| 68Ga-NYM096 PET/ CT for the Detection of ccRCC in Presurgical Patients With Complex Cystic Renal Leision (NCT06949215) | Peking Union Medical College Hospital | 2025-05-01 |
| A Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Inhaled H057 in the Treatment of Acute Exacerbations of Bronchiectasis (NCT06958861) | Shanghai Huilun Pharmaceutical Co., Ltd. | 2025-05-01 |
| Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma (NCT06983210) | Nagoya University | 2025-05-01 |
| Zanubrutinib Plus GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Follicular Lymphoma (NCT06918015) | Zhejiang Cancer Hospital | 2025-05-01 |
| Evaluate the Efficacy and Safety of NTQ5082 Capsules in Patients With Primary IgA Nephropathy (NCT06982040) | Nanjing Chia-tai Tianqing Pharmaceutical | 2025-05-01 |
| Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID) (NCT06721871) | Napo Pharmaceuticals, Inc. | 2025-05-01 |
| The Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Mild to Moderate Alzheimer's Disease (NCT06840054) | Tabriz University of Medical Sciences | 2025-05-01 |
| Study on GD2 Positive Solid Tumors by 4SCAR-GD2 (NCT02992210) | Shenzhen Geno-Immune Medical Institute | 2025-05-01 |
| Doravirine/Lamivudine (DOR/3TC) as a Maintenance ART in Comparison With Dolutegravir/Lamivudine (DTG/3TC) in PLWH Successfully (NCT06774872) | Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | 2025-04-30 |
| JS111 in Patients With Advanced NSCLC Harboring EGFR Mutations (NCT06940401) | Suzhou Junjing BioSciences Co., Ltd. | 2025-04-30 |
| Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients (NCT06931080) | Otsuka Pharmaceutical Co., Ltd. | 2025-04-30 |
| Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC. (NCT06911684) | Sun Yat-sen University | 2025-04-30 |
| Disitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer (NCT06957561) | Sun Yat-sen University | 2025-04-30 |
| A Study of ES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung Cancer (NCT06623136) | Elpiscience (Suzhou) Biopharma, Ltd. | 2025-04-30 |
| SHR0302 Combined With PD-1/PD-L1 Inhibition for Treatment naïve or Acquired Resistant to Immunology NSCLC (NCT06925048) | Chunxia Su | 2025-04-30 |
| Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity (NCT06909110) | Jessie L. Alexander | 2025-04-30 |
| A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin (NCT07109700) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2025-04-30 |
| Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repair Deficient Castration-resistant Prostate Cancer (NCT06527690) | Latin American Cooperative Oncology Group | 2025-04-30 |
| Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers (NCT06690177) | MediWound Ltd | 2025-04-30 |
| Glucokinase Activator in Monogenic Diabetes (NCT06976658) | Chinese University of Hong Kong | 2025-04-30 |
| Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies (NCT07064018) | University of California, Irvine | 2025-04-30 |
| A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects (NCT05913752) | Clearmind Medicine Inc. | 2025-04-30 |
| A Phase II Study Evaluating the Efficacy and Safety of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) (NCT06978699) | S-INFINITY Pharmaceuticals Co., Ltd | 2025-04-30 |
| Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma (NCT06328036) | National Cancer Institute (NCI) | 2025-04-30 |
| Clinical Trial of CD38 Monoclonal Antibody Combined With Chemotherapy for T-Cell Acute Lymphoblastic Leukemia (NCT07585734) | Institute of Hematology & Blood Diseases Hospital, China | 2025-04-30 |
| A Multicenter, Single-arm Phase II Study to Evaluate the Efficacy and Safety of Fulzerasib (IBI351) in Combination With Ivonescimab (AK-112) in First-line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer Patients With KRAS G12C Mutation (NCT06936644) | Shanghai Chest Hospital | 2025-04-30 |
| A Proof-of-concept Trial for OPC 131461 in Patients Hospitalized for Worsening Heart Failure (NCT06795399) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2025-04-30 |
| FGF19 Overexpression Combination Unified Study in HCC-19 (NCT06978933) | RenJi Hospital | 2025-04-30 |
| A Clinical Trial Evaluating the Safety and Efficacy of Myelin-peptide Loaded tolDC as Treatment for MS (NCT06715605) | University Hospital, Antwerp | 2025-04-30 |
| A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors. (NCT06907043) | Eikon Therapeutics | 2025-04-30 |
| A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer (NCT06926920) | Gilead Sciences | 2025-04-30 |
| Iparomlimab/Tuvonralimab Integrating With Total Neoadjuvant Therapy for pMMR/MSS Locally Advanced Rectal Cancer (IT-TNT) (NCT07026422) | Shandong Cancer Hospital and Institute | 2025-04-30 |
| A Study of AK130 in Combination With AK112 for the Treatment of Advanced Biliary Tract Cancer (NCT06938321) | Akeso | 2025-04-30 |
| A Multicenter Phase II Clinical Study of Neoadjuvant Use of Camrelizumab in Combination With Chemotherapy for Organ Preservation in Esophageal Cancer (NCT06869226) | Peking University Cancer Hospital & Institute | 2025-04-30 |
| IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer (NCT07692750) | Zhejiang Cancer Hospital | 2025-04-30 |
| NE3107 in Adults With Neurological Symptoms of Long COVID (NCT06847191) | BioVie Inc. | 2025-04-29 |
| Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer (NCT07066995) | Essen Biotech | 2025-04-29 |
| Study for AZD4360 in Participants With Advanced Solid Tumours (NCT06921928) | AstraZeneca | 2025-04-29 |
| Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer (NCT07067255) | Essen Biotech | 2025-04-29 |
| Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0 (NCT06488781) | University of Oklahoma | 2025-04-29 |
| Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory Multiple Myeloma (NCT07032129) | Essen Biotech | 2025-04-29 |
| A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizumab for Patients With Non-small Cell Lung Cancer With an STK11 Mutation. (NCT07207395) | The Christ Hospital | 2025-04-29 |
| Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder (NCT06846320) | AbbVie | 2025-04-29 |
| A Study of Ranolazine in ALS (NCT06527222) | Swathy Chandrashekhar, MBBS | 2025-04-29 |
| Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease (NCT06526299) | University of Washington | 2025-04-29 |
| Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation (NCT06990529) | Pharming Technologies B.V. | 2025-04-29 |
| Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease. (NCT06781333) | Bernard (Barry) Baumel | 2025-04-29 |
| Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer (NCT06918132) | Mayo Clinic | 2025-04-29 |
| Evaluating the Neuromodulatory Effect of Ketamine in Long COVID-19 (NCT06821087) | University of Texas at Austin | 2025-04-28 |
| Neoadjuvant CAPOX Plus Ivonescimab Versus CAPOX for Locally Advanced Colon Cancer (NCT06790212) | Sun Yat-sen University | 2025-04-28 |
| A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease. (NCT06632600) | Novartis Pharmaceuticals | 2025-04-28 |
| A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH) (NCT06836609) | Regeneron Pharmaceuticals | 2025-04-28 |
| Neoadjuvant QL1706 Therapy for ESCC (NCT06908382) | Shandong Provincial Hospital | 2025-04-28 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants (NCT06939777) | Sinovac Life Sciences Co., Ltd. | 2025-04-28 |
| A Trial to Evaluate the Safety and Efficacy of NCR102 in Subjects With aGVHD (NCT06941350) | Nuwacell Biotechnologies Co., Ltd. | 2025-04-28 |
| Comparison of Recurrence Rate of Keloid After Excision Between Intra-operative Steroid Injection and Steroid With Platelet-rich Plasma Injection Combination Therapy (NCT06965088) | Ramathibodi Hospital | 2025-04-28 |
| A Phase II Clinical Study of HRS-7058 in Combination With Antitumor Drugs in Patients With Advanced Malignant Tumour (NCT06915142) | Shandong Suncadia Medicine Co., Ltd. | 2025-04-28 |
| Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis (NCT06891040) | Jiangsu vcare pharmaceutical technology co., LTD | 2025-04-28 |
| Hybrid Arc Palliative Radiation Therapy (HART): A Single Arm Phase II Trial (NCT06778408) | University of Vermont Medical Center | 2025-04-28 |
| Neuroimaging of Escitalopram in Autism Spectrum Disorder (NCT06826326) | Kathryn Unruh | 2025-04-28 |
| Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer (NCT07002320) | Institute of Cancer Research, United Kingdom | 2025-04-28 |
| A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis (NCT06474442) | Shanghai BDgene Co., Ltd. | 2025-04-28 |
| Purpose of This Study is the Demonstration of Safety and Efficacy of the Dermal Fillers DXP01 Temporary Improvement of Moderate to Severe Nasolabial Folds (NCT06885775) | DEXLEVO | 2025-04-28 |
| A Study of Long-term Safety and Efficacy of VX-670 in Participants With Myotonic Dystrophy Type I (NCT06926621) | Vertex Pharmaceuticals Incorporated | 2025-04-28 |
| Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig) (NCT07202065) | Monash University | 2025-04-28 |
| Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981 (NCT06954766) | Chong Kun Dang Pharmaceutical | 2025-04-28 |
| Lead-212 PSV359 Therapy for Patients With Solid Tumors (NCT06710756) | Perspective Therapeutics | 2025-04-28 |
| Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy (NCT06937177) | Endevica Bio | 2025-04-28 |
| Secretin in Ex-situ Liver Perfusion (NCT07651748) | Erasmus Medical Center | 2025-04-26 |
| Dapagliflozin in Allo-HCT for aGVHD (NCT06626737) | The First Affiliated Hospital of Soochow University | 2025-04-26 |
| Selinexor Combined With Azacitidine Therapy in High-Risk Myeloid Neoplasms Patients (NCT06900088) | Institute of Hematology & Blood Diseases Hospital, China | 2025-04-25 |
| Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors (NCT06414460) | InSilico Medicine Hong Kong Limited | 2025-04-25 |
| Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC) (NCT06943235) | Fudan University | 2025-04-25 |
| IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL (NCT06768905) | University of Texas Southwestern Medical Center | 2025-04-25 |
| Glumetinib Combined With Fruquintinib in the Treatment of MET Amplification or Protein Overexpression in Third-Line Unresectable Metastatic Colorectal Cancer (NCT06980532) | Liu Huang | 2025-04-25 |
| A Study of ERAS-601 in People With Chordoma (NCT06957327) | Memorial Sloan Kettering Cancer Center | 2025-04-25 |